Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes

Author:

Ardoino Ilaria1,Mandelli Sara1,Baviera Marta2,Rossio Raffaella3,Nobili Alessandro1,Mannucci Pier Mannuccio4ORCID,Franchi Carlotta15ORCID,

Affiliation:

1. Laboratory of Pharmacoepidemiology and Human Nutrition, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy

2. Laboratory of Cardiovascular Prevention, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy

3. Department of Pathophysiology and Transplantation, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy

4. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy

5. Italian Institute For Planetary Health (IIPH), 20156 Milan, Italy

Abstract

Objective: To describe the prescription pattern of antidiabetic and cardiovascular drugs in a cohort of hospitalized older patients with diabetes. Methods: Patients with diabetes aged 65 years or older hospitalized in internal medicine and/or geriatric wards throughout Italy and enrolled in the REPOSI (REgistro POliterapuie SIMI—Società Italiana di Medicina Interna) registry from 2010 to 2019 and discharged alive were included. Results: Among 1703 patients with diabetes, 1433 (84.2%) were on treatment with at least one antidiabetic drug at hospital admission, mainly prescribed as monotherapy with insulin (28.3%) or metformin (19.2%). The proportion of treated patients decreased at discharge (N = 1309, 76.9%), with a significant reduction over time. Among those prescribed, the proportion of those with insulin alone increased over time (p = 0.0066), while the proportion of those prescribed sulfonylureas decreased (p < 0.0001). Among patients receiving antidiabetic therapy at discharge, 1063 (81.2%) were also prescribed cardiovascular drugs, mainly with an antihypertensive drug alone or in combination (N = 777, 73.1%). Conclusion: The management of older patients with diabetes in a hospital setting is often sub-optimal, as shown by the increasing trend in insulin at discharge, even if an overall improvement has been highlighted by the prevalent decrease in sulfonylureas prescription.

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference38 articles.

1. World Health Organization (2022, December 02). Diabetes. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes.

2. International Diabetes Federation (2021). Diabetes Atlas 2021, International Diabetes Federation. [10th ed.]. Available online: https://diabetesatlas.org/.

3. International Diabetes Federation (2022, December 02). Diabetes in Europe. Policy Puzzle. The State We Are in. Available online: https://www.idf.org/our-network/regions-members/europe/publications-and-resources/56-diabetes-in-europe-policy-puzzle.html.

4. Management of diabetes mellitus in older people with comorbidities;Huang;BMJ,2016

5. Di Martino, G., Di Giovanni, P., Cedrone, F., Meo, F., Scampoli, P., Romano, F., and Staniscia, T. (2021). Hospitalization for Short-Term Diabetes-Related Complications: Focus on Patients aged over 85 years. Healthcare, 9.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3